MAY 11, 2016 02:07 PM PDT

Pathogen-specific antibiotics protect gut bacteria

WRITTEN BY: Kerry Evans
5 8 1244
You take antibiotics for an infection, right? Broad-spectrum antibiotics kill the harmful bacteria, yes. The problem is that they also kill your beneficial gut microbes - those guys that help you digest food and provide vitamins.

Researchers at St. Jude Children’s Research Hospital demonstrated that a Staphylococcus aureus-specific antibiotic called Debio 1452 (produced by Debiopharm International) effectively spared much of the gut microbiome when given orally to mice.
 
Broad-spectrum antibiotics damage the microbiome.

According to study author Charles Rock, “in this study, we demonstrated that the pathogen-selective approach to antibiotic development is an effective way to minimize collateral damage to beneficial bacteria in the gut microbiome. Such treatment strategies will become increasingly important for use in antibiotic drug design thanks to the growing awareness of the vital role that the gut microbiome plays in digestion and immune protection.”

The antibiotic works by blocking the activity of an enzyme called FabI. Staph needs this enzyme to grow, but most other bacteria do not.

The group compared the effect of Debio 1452 and broad-spectrum antibiotics (linezolid, clindamycin, amoxicillin, of moxifloxacin) on the gut bacteria of mice. They used next-generation sequencing techniques to identify and quantify bacteria from stool samples.

The broad-spectrum antibiotics decreased the abundance of gut microbes up to 4,000 fold! (That’s a lot.) Debio 1452, on the other hand, had little effect. What’s more, the concentration of Debio in mice was 12 times higher than what would be given to humans!

Broad-spectrum antibiotics also decreased the diversity of gut bacteria, but Debio 1452 altered diversity very little. Interestingly, the quantity of bacteria depleted with the broad-spectrum antibiotics returned to normal within a week, but diversity remained skewed.

This pathogen-specific approach does have an obvious drawback, however. It requires researchers to identify factors - enzymes, for example - that are essential to each pathogen and design a drug to specifically target that weakness.

Sources: Antimicrobial Agents and Chemotherapy, Alpha Galileo
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
MAY 07, 2018
Microbiology
MAY 07, 2018
West Nile Virus May Now Have a Treatment
West Nile Virus is a mosquito-borne disease with no effective treatments and no vaccine. That may be changing.
JUN 28, 2018
Videos
JUN 28, 2018
A Vaccine for Syphilis is in the Works
Now that the scientists have studied the protein and its potential, they will begin to enroll participants in a study.
JUL 03, 2018
Microbiology
JUL 03, 2018
Undiagnosed Zika Infections may be Causing Miscarriage and Stillbirth
Zika virus might still be impacting pregnancies.
JUL 16, 2018
Microbiology
JUL 16, 2018
Cyclospora to Blame for Several Foodborne Outbreaks
One outbreak of cyclosporiasis, which is caused by a parasite, has been traced back to salads sold at McDonald's, mostly in the Midwest.
JUL 17, 2018
Microbiology
JUL 17, 2018
Understanding how Microbes Will Accelerate Climate Change
As permafrost starts to thaw out, it's exposing untold numbers of new bacteria, which can spew out methane.
AUG 12, 2018
Microbiology
AUG 12, 2018
What Allows Some Microbes to Live in the Gut?
Microbes have to first pass through the harsh stomach environment to colonize the gastrointestinal tract.
Loading Comments...